LGND - Ligand Pharmaceuticals' (LGND) CEO John Higgins on Q1 2019 Results - Earnings Call Transcript
Ligand Pharmaceuticals Inc. (LGND)
Q1 2019 Earnings Conference Call
May 2, 2019 4:30 PM ET
Company Participants
Todd Pettingill – Investor Relations
John Higgins – Chief Executive Officer
Matt Foehr – Chief Operating Officer
Matt Korenberg – Chief Financial Officer
Conference Call Participants
Larry Solow – CJS Securities
Presentation
Operator
Hello, and welcome to the Ligand Pharmaceuticals Q1 2019 Earnings Call. My name is Ian, and I will be your web event specialist today. [Operator Instructions]
And my pleasure to turn webcast over to Todd Pettingill. Todd, the floor is yours.
Todd Pettingill
Welcome to